CVA
TMO icon

Central Valley Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Central Valley Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-262
Closed -$316K – 168
2024
Q2 		$316K Sell
262
-104
-28% -$59.6K 0.13% 92
2024
Q1 		$213K Buy
+366
New +$205K 0.11% 144

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Central Valley Advisors's TMO Position: Q3 2024 in Review

Central Valley Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 262 shares — an estimated $316K sold.

Central Valley Advisors first reported a position in TMO in Q1 2024 and held it in 2 quarters. The position peaked at $316K in Q2 2024. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • Central Valley Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
  • Central Valley Advisors sold 262 Thermo Fisher Scientific shares in Q3 2024, an estimated $316K.
  • Central Valley Advisors first reported a position in Thermo Fisher Scientific in Q1 2024 and held it in 2 quarters.
  • Central Valley Advisors's Thermo Fisher Scientific position peaked at $316K in Q2 2024.
  • 2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Central Valley Advisors's 13F filing for Q3 2024, filed 4 Oct 2024.